Handelsbanken Fonder
ZBH icon

Handelsbanken Fonder’s Zimmer Biomet ZBH Stock Holding History

Handelsbanken Fonder’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1M Buy
152,064
+28,130
+23% +$2.47M 0.04% 341
2026
Q1 		$11.2M Buy
+123,934
New +$11.4M 0.04% 353
2025
Q4 		– Sell
-124,830
Closed -$12.3M – 1563
2025
Q3 		$12.3M Sell
124,830
-985
-0.8% -$97.6K 0.04% 341
2025
Q2 		$11.5M Sell
125,815
-12,627
-9% -$1.22M 0.04% 335
2025
Q1 		$15.7M Buy
138,442
+1,063
+0.8% +$114K 0.06% 265
2024
Q4 		$14.5M Sell
137,379
-62,890
-31% -$6.75M 0.06% 291
2024
Q3 		$21.6M Sell
200,269
-107,194
-35% -$11.7M 0.09% 219
2024
Q2 		$33.4M Buy
307,463
+23,193
+8% +$2.73M 0.15% 143
2024
Q1 		$37.5M Buy
284,270
+91,151
+47% +$11.4M 0.16% 139
2023
Q4 		$23.5M Sell
193,119
-135,747
-41% -$15.1M 0.11% 190
2023
Q3 		$36.9M Sell
328,866
-44,543
-12% -$5.66M 0.21% 111
2023
Q2 		$54.4M Buy
373,409
+13,004
+4% +$1.77M 0.29% 70
2023
Q1 		$46.6M Buy
360,405
+5,251
+1% +$659K 0.27% 82
2022
Q4 		$45.3M Sell
355,154
-417
-0.1% -$48.4K 0.28% 83
2022
Q3 		$37.2M Sell
355,571
-96,957
-21% -$10.6M 0.25% 94
2022
Q2 		$47.5M Buy
452,528
+45,133
+11% +$5.35M 0.31% 74
2022
Q1 		$52.1M Sell
407,395
-20,874
-5% -$2.52M 0.29% 75
2021
Q4 		$52.8M Sell
428,269
-21,524
-5% -$2.82M 0.26% 84
2021
Q3 		$63.9M Buy
449,793
+11,546
+3% +$1.7M 0.33% 60
2021
Q2 		$68.4M Buy
438,247
+5,092
+1% +$825K 0.36% 61
2021
Q1 		$67.3M Buy
433,155
+98,180
+29% +$15.2M 0.38% 63
2020
Q4 		$50.1M Buy
334,975
+1,395
+0.4% +$197K 0.3% 82
2020
Q3 		$44.1M Sell
333,580
-24,308
-7% -$3.18M 0.32% 72
2020
Q2 		$41.5M Buy
+357,888
New +$41.2M 0.35% 67
2016
Q1 		– Sell
-36,005
Closed -$3.59M – 604
2015
Q4 		$3.59M Buy
+36,005
New +$3.52M 0.07% 235

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Handelsbanken Fonder's ZBH Position: Q2 2026 in Review

Handelsbanken Fonder increased its Zimmer Biomet (ZBH) stake by 23% in Q2 2026, buying an estimated $2.47M and bringing the position to 152,064 shares worth $13.1M. The position accounts for 0.04% of the portfolio, ranked #341.

Handelsbanken Fonder first reported a position in ZBH in Q4 2015 and has held it in 25 quarters since. The position peaked at $68.4M in Q2 2021. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Handelsbanken Fonder held 152,064 shares of Zimmer Biomet worth $13.1M as of Q2 2026.
  • Handelsbanken Fonder bought 28,130 Zimmer Biomet shares in Q2 2026, an estimated $2.47M.
  • Zimmer Biomet made up 0.04% of Handelsbanken Fonder's portfolio in Q2 2026, its #341 holding.
  • Handelsbanken Fonder first reported a position in Zimmer Biomet in Q4 2015 and has held it in 25 quarters since.
  • Handelsbanken Fonder's Zimmer Biomet position peaked at $68.4M in Q2 2021.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.